ISRCTN20279720已完成未知
Brain Development after prenatal growth retardation: effects of growth hormone treatment
Pfizer B.V. (The Netherlands)0 个研究点目标入组 110 人开始时间: 2007年2月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Inclusion criteria group A/B:
- •1. Birth weight or birth length below -2 Standard Deviation (SD) adjusted for duration of pregnancy
- •2. Present height below -2.5 SD and at least 1 SD below target height-SD score
- •3. Calendar age between four and six years
- •4. No evidence of catch up growth during the preceding year
- •5. Children are under regular control by pediatrician, choose to be or not to be treated with Growth Hormone (GH)
- •Inclusion criteria group C:
- •1. Birth weight or birth length below -2 SD adjusted for duration of pregnancy
- •2. Present height above -2.0 SD and above minus 1 SD of target height -SD score
- •Inclusion criteria group D:
- •1. Normal birth weight/length adjusted for duration of pregnancy
- •2. Present height above -2 SD for age and within target range (Target Height [TH] ± 1 SD)
排除标准
- •1. Known syndromes and serious dysmorphic symptoms suggestive for a syndrome that has not yet been described, except for Silver Russell Syndrome
- •2. Severe asphyxia (defined as Apgar score less than three after 5 minutes), and no serious diseases such as long-term artificial ventilation and oxygen supply, bronchopulmonary dysplasia or other chronic lung disease
- •3. Coeliac disease and other chronic or serious diseases of the gastrointestinal tract, heart, genito-urinary tract, liver, lungs, skeleton or central nervous system, or chronic or recurrent major infectious diseases, nutritional and/or vitamin deficiencies
- •4. Any endocrine or metabolic disorder such as diabetes mellitus, diabetes insipidus, hypothyroidism, or inborn errors of metabolism, except of Growth Hormone Deficiency (GHD)
- •5. Medications or interventions during the previous six months that might have interfered with growth, such as corticosteroids (including high dose of corticosteroid inhalation), sex steroids, growth hormone, or major surgery (particularly of the spine or extremities)
- •6. Use of medication that might interfere with growth during GH therapy, such as corticosteroids, sex steroids, Luteinising Hormone-Releasing Hormone (LHRH) analogue
- •7. Active or treated malignancy or increased risk of leukaemia
- •8. Serious suspicion of psychosocial dwarfism (emotional deprivation)
- •9. Severe neurological disability
- •10. Expected non-compliance
- •11. Prematurity less than 35 weeks
- •12. For Magnetoencephalography (MEG)/Magnetic Resonance Imaging (MRI) investigation: treatment with irremovable metal wires
研究者
相似试验
尚未招募
不适用
Brain development after prenatal growth retardation; effects of growth hormone treatmentsmall for gestational age / intra uterine growth failure1002111210010273NL-OMON30243Vrije Universiteit Medisch Centrum110
尚未招募
不适用
Brain development after prenatal growth retardation; effects of growth hormone treatment.Study populations:group A/B: small for gestational age (sga), children without complete catch up growth with and without growth hormone treatmentgroup C: sga with complete catch up growth group D:. Children born with a normal birth weight/length and a normal postnatal growth.NL-OMON29167Prof Dr HA Delemarre- van de Waal110
招募中
不适用
The Structural Change of Fetal Brain Development among Diabetic Mother in Bhumibol Adulyadej HospitalFetal distress or fetal demise.Maternal complication such as pre-eclampsiafetal brain structures, diabetes pregnant woman, gestational diabetesTCTR20240503001Bhumibol Adulyadej Hospital310
招募中
不适用
ormal fetal neurodevelopment; healthy control population as a comparison for fetuses with a congenital heart diseaseCongenital heart diseaseIntra-uterine neurodevelopmental disordersNL-OMON26893eiden University Medical Center70
尚未招募
不适用
A study to document the long-term benefits of Kangaroo Mother Care (skin to skin contact and exclusive breast feeding) initiated at home during neonatal period on brain development at 6-7 years of child age.CTRI/2021/09/036103Centre for Health Research and Development Society for Applied Studies